- Home
- CRESY vs BBOT Comparison
CRESY vs BBOT Comparison
Compare CRESY & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRESY | BBOT |
|---|---|---|
| Founded | 1936 | 2016 |
| Country | Argentina | United States |
| Employees | 2889 | 106 |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.2M | 705.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRESY | BBOT |
|---|---|---|
| Price | $11.79 | $8.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 254.0K | ★ 375.0K |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | ★ 8.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.39 | $7.60 |
| 52 Week High | $14.21 | $14.87 |
Technical Indicators
Market Signals| Indicator | CRESY | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 48.76 |
| Support Level | $11.12 | $8.08 |
| Resistance Level | $12.25 | $9.73 |
| Average True Range (ATR) | 0.42 | 0.59 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 96.09 | 56.02 |
Price Performance
Historical ComparisonAbout CRESY Cresud S.A.C.I.F. y A.
Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.